WESTERN ASSET EMRG MRKT DBT (EMD) Stock Price, Forecast & Analysis
USA - NYSE:EMD - US95766A1016
10.42 USD
-0.05 (-0.48%)
EMD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. EMD has a bad profitability rating. Also its financial health evaluation is rather negative. EMD does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year EMD was profitable.
EMD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: EMD reported negative net income in multiple years.
Each year in the past 5 years EMD had a positive operating cash flow.
1.2 Ratios
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.19% | ||
| ROE | 11.56% | ||
| ROIC | 3.92% |
ROA(3y)-4.11%
ROA(5y)0.31%
ROE(3y)-5.67%
ROE(5y)0.48%
ROIC(3y)4.01%
ROIC(5y)3.96%
1.3 Margins
In the last couple of years the Profit Margin of EMD has grown nicely.
In the last couple of years the Operating Margin of EMD has declined.
EMD's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 65.77% | ||
| PM (TTM) | 108.65% | ||
| GM | 66.08% |
OM growth 3Y-5.61%
OM growth 5Y-2.37%
PM growth 3Y19.94%
PM growth 5YN/A
GM growth 3Y-5.63%
GM growth 5Y-2.25%
2. Health
2.1 Basic Checks
The number of shares outstanding for EMD has been reduced compared to 1 year ago.
The number of shares outstanding for EMD has been reduced compared to 5 years ago.
Compared to 1 year ago, EMD has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 1.08, we must say that EMD is in the distress zone and has some risk of bankruptcy.
EMD has a debt to FCF ratio of 4.92. This is a neutral value as EMD would need 4.92 years to pay back of all of its debts.
A Debt/Equity ratio of 0.40 indicates that EMD is not too dependend on debt financing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 4.92 | ||
| Altman-Z | 1.08 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
EMD has a Current Ratio of 0.03. This is a bad value and indicates that EMD is not financially healthy enough and could expect problems in meeting its short term obligations.
EMD has a Quick Ratio of 0.03. This is a bad value and indicates that EMD is not financially healthy enough and could expect problems in meeting its short term obligations.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.03 | ||
| Quick Ratio | 0.03 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 149.96% over the past year.
The Earnings Per Share has been growing by 16.13% on average over the past years. This is quite good.
The Revenue has grown by 8.04% in the past year. This is quite good.
The Revenue has been decreasing by -5.61% on average over the past years.
EPS 1Y (TTM)149.96%
EPS 3Y16.13%
EPS 5YN/A
EPS Q2Q%14.91%
Revenue 1Y (TTM)8.04%
Revenue growth 3Y-4.32%
Revenue growth 5Y-5.61%
Sales Q2Q%10.24%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 8.40, the valuation of EMD can be described as reasonable.
The average S&P500 Price/Earnings ratio is at 26.03. EMD is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.4 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.91 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
EMD has a Yearly Dividend Yield of 10.46%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.38, EMD pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.46% |
5.2 History
The dividend of EMD decreases each year by -5.11%.
EMD has paid a dividend for at least 10 years, which is a reliable track record.
EMD has decreased its dividend recently.
Dividend Growth(5Y)-5.11%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
76.80% of the earnings are spent on dividend by EMD. This is not a sustainable payout ratio.
DP76.8%
EPS Next 2YN/A
EPS Next 3YN/A
NYSE:EMD (11/4/2025, 8:20:13 PM)
10.42
-0.05 (-0.48%)
Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)
Earnings (Next)
Inst Owners46.52%
Inst Owner Change-2.3%
Ins Owners0%
Ins Owner Change12.65%
Market Cap605.71M
Revenue(TTM)65.72M
Net Income(TTM)71.40M
Analysts0
Price TargetN/A
Short Float %0.15%
Short Ratio0.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.46% |
Yearly Dividend0.92
Dividend Growth(5Y)-5.11%
DP76.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.4 | ||
| Fwd PE | N/A | ||
| P/S | 9.22 | ||
| P/FCF | 11.91 | ||
| P/OCF | 11.91 | ||
| P/B | 0.98 | ||
| P/tB | 0.98 | ||
| EV/EBITDA | N/A |
EPS(TTM)1.24
EY11.9%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.87
FCFY8.4%
OCF(TTM)0.87
OCFY8.4%
SpS1.13
BVpS10.62
TBVpS10.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number17.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.19% | ||
| ROE | 11.56% | ||
| ROCE | 4.97% | ||
| ROIC | 3.92% | ||
| ROICexc | 3.92% | ||
| ROICexgc | 3.93% | ||
| OM | 65.77% | ||
| PM (TTM) | 108.65% | ||
| GM | 66.08% | ||
| FCFM | 77.39% |
ROA(3y)-4.11%
ROA(5y)0.31%
ROE(3y)-5.67%
ROE(5y)0.48%
ROIC(3y)4.01%
ROIC(5y)3.96%
ROICexc(3y)4.01%
ROICexc(5y)3.96%
ROICexgc(3y)4.03%
ROICexgc(5y)3.97%
ROCE(3y)5.14%
ROCE(5y)5.17%
ROICexgc growth 3Y3.16%
ROICexgc growth 5Y-0.64%
ROICexc growth 3Y3.28%
ROICexc growth 5Y-0.54%
OM growth 3Y-5.61%
OM growth 5Y-2.37%
PM growth 3Y19.94%
PM growth 5YN/A
GM growth 3Y-5.63%
GM growth 5Y-2.25%
F-Score5
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.4 | ||
| Debt/FCF | 4.92 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 71.23% | ||
| Current Ratio | 0.03 | ||
| Quick Ratio | 0.03 | ||
| Altman-Z | 1.08 |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)149.96%
EPS 3Y16.13%
EPS 5YN/A
EPS Q2Q%14.91%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.04%
Revenue growth 3Y-4.32%
Revenue growth 5Y-5.61%
Sales Q2Q%10.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-5.24%
EBIT growth 3Y-9.69%
EBIT growth 5Y-7.85%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-70.23%
FCF growth 3Y-18.12%
FCF growth 5Y3.58%
OCF growth 1Y-70.23%
OCF growth 3Y-18.12%
OCF growth 5Y3.58%
WESTERN ASSET EMRG MRKT DBT / EMD FAQ
Can you describe the business of WESTERN ASSET EMRG MRKT DBT?
Western Asset Emerging Markets Debt Fund Inc is a US-based company operating in industry. The company is headquartered in New York City, New York. The company went IPO on 2003-12-02. Western Asset Emerging Markets Debt Fund Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to seek high current income, and its secondary objective is to seek capital appreciation. The company invests primarily in the United States (U.S.) dollar and non-United States dollar denominated debt securities of issuers in emerging market countries. The Fund invests at least 80% of its managed assets in debt securities of issuers in emerging market countries. The Fund may invest up to 20% of its managed assets in non-debt securities and non-emerging market issuers, including equity securities. The company may invest in securities denominated in currencies of emerging market countries. The Fund seeks to maintain an average portfolio duration between 20% above and 20% below the average duration of the JPMorgan Emerging Markets Bond Index Global Diversified. Its investment manager is Franklin Templeton Fund Adviser, LLC.
What is the stock price of WESTERN ASSET EMRG MRKT DBT today?
The current stock price of EMD is 10.42 USD. The price decreased by -0.48% in the last trading session.
What is the ChartMill technical and fundamental rating of EMD stock?
EMD has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.